Estate Planners Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-175
Closed -$21.4K 423
2025
Q4
$21.4K Buy
+175
New +$20.1K 0.01% 204

Other funds holding XBI

Estate Planners Group's XBI Position: Q1 2026 in Review

Estate Planners Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 175 shares — an estimated $21.4K sold.

Estate Planners Group first reported a position in XBI in Q4 2025 and held it in 1 quarter. The position peaked at $21.4K in Q4 2025. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Estate Planners Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • Estate Planners Group sold 175 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $21.4K.
  • Estate Planners Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and held it in 1 quarter.
  • Estate Planners Group's State Street SPDR S&P Biotech ETF position peaked at $21.4K in Q4 2025.
  • 816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.